首页|首次与二次新型冠状病毒感染患者的心理健康状况比较

首次与二次新型冠状病毒感染患者的心理健康状况比较

扫码查看
目的:比较首次与二次新型冠状病毒感染对大众心理健康状况的影响.方法:通过问卷星平台,在2022年12月至2023年1月,采用冠状病毒焦虑量表(CAS)、简版流调中心抑郁量表(CES-D)、失眠严重指数量表(ISI)、Connor-Davidson弹性量表(CD-RISC)、斯坦福急性应激反应问卷(SASRQ)对大众焦虑、抑郁、睡眠情况、心理弹性、心理应激进行评估.结果:二次感染者的CAS、CES-D、ISI及SASRQ评分均高于首次感染者(P<0.001);二次感染者焦虑、抑郁、失眠、应激障碍的患病率显著高于首次感染者(P<0.05);控制潜在的混杂因素后,二次感染者在焦虑(OR=2.738)、失眠(OR=1.730)、急性应激障碍(OR=2.481)患病率显著高于首次感染者(P<0.01).结论:二次新型冠状病毒感染者心理健康问题的患病率显著高于首次感染者,且二次感染可能是焦虑、失眠、急性应激障碍的重要危险因素.
Comparison of mental health status of COVID-19 patients between single and secondary infections
Objective:To compare the effect of single and secondary CO VID-19 on population mental health.Methods:From December 2022 to January 2023,public anxiety,depression,sleep,resilience and psychological stress were evaluated through Coronavirus Anxiety Scale(CAS),Center For Epi-demic Depression Scale(CES-D),Insomnia Severity Index Scale(ISI),Connor-Davidson Elasticity Scale(CD-RISC),and Stanford Acute Stress Response Questionnaire(SASRQ).Results:The scores of CAS,CES-D,ISI,and SASRQ of the second COVID-19 patients were higher than those of the single infection(P<0.001).The prevalence of anxiety,depression,insomnia,and stress disorder among the secondary COVID-19 patients was significantly higher than that respectively in the single-in-fected patients(P<0.05).After the potential confounding factors were controlled,the prevalence of anxiety(OR=2.738),insomnia(OR=1.730),and acute stress disorder(OR=2.481)in the second infected patients in COVID-19 was significantly higher than that respectively in the single infected peo-ple(P<O.01).Conclusion:The prevalence of mental health problems in the secondary infected pa-tients is significantly higher than that in the single infected patients.The secondary COVID-19 may be a risk factor for anxiety,insomnia,and acute stress disorder.

COVID-19Mental Health StatusAcute Stress DisorderSecondary Infection

王晶、胡营营、赵文艳、周玉亮、徐志鹏、朱虹

展开 >

武汉大学中南医院神经心理科 湖北 武汉 430071

新型冠状病毒感染 心理健康状况 急性应激障碍 二次感染

湖北省重点研发计划

2022BCA039

2024

武汉大学学报(医学版)
武汉大学

武汉大学学报(医学版)

CSTPCD
影响因子:0.959
ISSN:1671-8852
年,卷(期):2024.45(5)
  • 28